HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Shiseido Skin Care For Gen-Z Men; e.l.f. Cosmetics For Gamers; Summer Beauty Launches In Brief

Executive Summary

L’Oreal Paris delivers permanent hair color designed specifically for men, Shiseido targets new skin care to Gen-Z males, and e.l.f. Beauty continues to play nice with gamers, launching a limited-edition Game Up cosmetics range. More product launch news in brief.

You may also be interested in...

Clothing Retail Giant H&M Debuts Beauty Flagship Stores In Norway, Launches Body Care Lines

H&M opens two flagship H&M Beauty stores in Oslo where consumers can shop for cosmetics, skin and hair care, to create one-stop shop for beauty and fashion. Each store is about 300 square meters within existing H&M stores and with its own entrance, offering its own beauty label products along with 80 third-party brands.

Kohl’s Anticipates $2Bn In Sales By 2025 From ‘Game Changing’ Sephora Installations

Kohl’s reports its Sephora at Kohl’s beauty store-within-store has brought 1 million new customers – largely young and diverse – since it launched last August, with $2bn in sales targeted by 2025.

E.l.f. Hoists 2023 Full-Year Sales Guidance As Value Prices Attract New Customers

E.l.f. Beauty’s sales grew 26% to $122.6m in the fiscal 2023 first quarter, leading the Oakland, CA-based firm to increase full-year projections. According to company leadership, e.l.f. is capturing market share at a rapid clip while expanding distribution, notably in pharmacy retail.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts